There are 3 companies in the insurance industry called a Pharmacy Benefits Managers (PBM) that decide how much you pay for prescriptions. A pharmacy can buy a drug for $4 but the PBM will charge you whatever they want. Check out these companies
NEW: Florida hits CVS with antitrust subpoenas over predatory drug pricing allegations
@AGJamesUthmeier: “Here you have a situation where it appears one company has gotten so big that they are controlling market power in a way that might manipulate pricing at the cost of consumers.”
"After all, nothing says 'safety net' quite like five publicly traded mega-corporations capturing 77% of all 340B contract pharmacy relationships." @DrugChannels
https://t.co/SQJEilRyzg
Today marks the 9th anniversary of the Play Like a Jet podcast. Can’t believe I’ve been talking about #Jets on a daily basis for so long haha. A sincere thank you to all who continue to listen & hopefully those who will join along if the team ever gets good again haha.
CVS spending over $7million in Tenn to protect their monopoly, silo access and increase costs! The country has had enough as more states follow Arkansas’s @SarahHuckabee lead to empower patient choice and access!
Had two great days on the hill fighting to keep Independent Pharmacies open and community’s served! Let’s goooo!
Huge thank you to @BettyMcCollum04 for co-sponsoring H.R. 6609 and H.R.6610 the Pharmacists Fight Back Act!
Thank you for supporting your community pharmacies!!
@Commpharmacy@MN_Indys@stpcornerdrug@loegering1186
Thank you, @SecKennedy, for highlighting the abuses of Pharmacy Benefit Managers (PBMs) and my recent legislation, which was signed into law and is the most significant PBM reform in decades.
There is more work to be done, but I’m happy to have this administration’s support in reining in PBMs to lower the cost of prescription medicine!
Terminally-ill cancer patient needs #180 oxycodone 5mg tablets filled.
They’ve met their OOP for the year with @WellcarePlans, so all of their co-pays are now $0 at the pharmacy counter for the rest of the year.
@WellcarePlans pay us $12.15 for those #180 tablets while they pay the Walmart down the road $80.07 for the same prescription on the same insurance plan!
How the fuck is that even close to being fair?
Walmart and our independent pharmacy are both standard “in-network” pharmacies by @CMSGov standards.
Why the huge discrepancy in reimbursements?
Where are you at @FTC, how are the other 2 settlements with the large PBMs going?
@WellcarePlans uses @ExpressScripts as their wonderful PBM!
The same entity you all “settled” up with a few short months ago.
This is why your local pharmacies are shutting down nationwide.
The playing field is no where close to being fair.
CVS accused of overbilling feds $600M in scheme. Very troubling findings. The same or more egregious findings can be expected in the commercial sector aka self-funded plans. Take a look at my article.
#PBMs#PBMReform#OIGAudit#PharmacyLaw#PharmacyLawyer
https://t.co/tTJuYkIHrz
Nobody needs a PBM. there’s no unique function that they provide that is needed.
They don’t research or develop medications, they don’t manufacture the medication, they don’t deliver the medication’s, they don’t store the medication‘s, they don’t dispense the medications. They do get to decide with medication’s. We can access and at what price and then so doing so extract billions of hours from the system.
They also underpaid competing independent, pharmacies, and drive them out of business.
Humana Is Prioritizing Profits Over Patients
It is absolutely unbelievable how the pharmaceutical middleman system works against the very people it’s supposed to serve. We just saw a massive shift in the market for Farxiga—a drug used by millions for diabetes and heart failure.
Yesterday, the manufacturer’s exclusive rights ended, which triggered a staggering 95% price drop. We’re talking about a medication that used to cost $350 yesterday and is now available for under $20 today at our pharmacy.
You would think a 95% decrease in cost would be a win for everyone, right? Especially for Medicare, which spends roughly $4 billion a year on this drug alone. This price drop could have saved them $3.9 billion annually.
Instead, Humana responded by removing the generic version of Farxiga from their formulary entirely the very day the price dropped.
Rather than passing these massive savings on to the patients, Pharmacy Benefit Managers (PBMs) chose to pull the plug. Why? Because PBMs are often built on a model that thrives on high list prices and back-end rebates. When the price hits the floor, their incentive to carry the drug disappears.
This is exactly why we decided to move away from the traditional middleman model. When the market price of a drug drops, our patients see that savings instantly. There is no waiting period, no formulary games, and no hidden fees.
If the drug goes cheap, you get it cheap. It's that simple.
If you are tired of being overcharged or having your essential medications removed from coverage just as they become affordable, it is time to look at your options.
The whole point of a retail business is to sell a product for more than you bought it for (plus your service). That's kind of impossible in retail pharmacy when insurance companies want to pay the competition less so they can get more. I love the PBM model.